33523018|t|Neuroprotective Effects of a GLP-2 Analogue in the MPTP Parkinson's Disease Mouse Model.
33523018|a|BACKGROUND: Glucagon-like peptide 2 (GLP-2) is a peptide hormone derived from the proglucagon gene expressed in the intestines, pancreas and brain. Some previous studies showed that GLP-2 improved aging and Alzheimer's disease related memory impairments. Parkinson's disease (PD) is a progressive neurodegenerative disorder, and to date, there is no particular medicine reversed PD symptoms effectively. OBJECTIVE: The aim of this study was to evaluate neuroprotective effects of a GLP-2 analogue in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) PD mouse model. METHODS: In the present study, the protease resistant Gly(2)-GLP-2 (50 nmol/kg ip.) analogue has been tested for 14 days by behavioral assessment, transmission electron microscope, immunofluorescence histochemistry, enzyme-linked immunosorbent assay and western blot in an acute PD mouse model induced by MPTP. For comparison, the incretin receptor dual agonist DA5-CH was tested in a separate group. RESULTS: The GLP-2 analogue treatment improved the locomotor and exploratory activity of mice, and improved bradykinesia and movement imbalance of mice. Gly(2)-GLP-2 treatment also protected dopaminergic neurons and restored tyrosine hydroxylase expression levels in the substantia nigra. Gly(2)-GLP-2 furthermore reduced the inflammation response as seen in lower microglia activation, and decreased NLRP3 and interleukin-1beta pro-inflammatory cytokine expression levels. In addition, the GLP-2 analogue improved MPTP-induced mitochondrial dysfunction in the substantia nigra. The protective effects were comparable to those of the dual agonist DA5-CH. CONCLUSION: The present results demonstrate that Gly(2)-GLP-2 can attenuate NLRP3 inflammasome-mediated inflammation and mitochondrial damage in the substantia nigra induced by MPTP, and Gly(2)-GLP-2 shows neuroprotective effects in this PD animal model.
33523018	51	55	MPTP	Chemical	MESH:D015632
33523018	56	75	Parkinson's Disease	Disease	MESH:D010300
33523018	76	81	Mouse	Species	10090
33523018	101	124	Glucagon-like peptide 2	Gene	93896
33523018	126	131	GLP-2	Gene	93896
33523018	271	276	GLP-2	Gene	93896
33523018	296	315	Alzheimer's disease	Disease	MESH:D000544
33523018	324	342	memory impairments	Disease	MESH:D008569
33523018	344	363	Parkinson's disease	Disease	MESH:D010300
33523018	365	367	PD	Disease	MESH:D010300
33523018	386	412	neurodegenerative disorder	Disease	MESH:D019636
33523018	468	470	PD	Disease	MESH:D010300
33523018	593	640	1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine	Chemical	MESH:D015632
33523018	642	646	MPTP	Chemical	MESH:D015632
33523018	648	650	PD	Disease	MESH:D010300
33523018	651	656	mouse	Species	10090
33523018	718	724	Gly(2)	Chemical	MESH:D006033
33523018	725	730	GLP-2	Gene	93896
33523018	943	945	PD	Disease	MESH:D010300
33523018	946	951	mouse	Species	10090
33523018	969	973	MPTP	Chemical	MESH:D015632
33523018	1026	1032	DA5-CH	Chemical	-
33523018	1154	1158	mice	Species	10090
33523018	1173	1185	bradykinesia	Disease	MESH:D018476
33523018	1212	1216	mice	Species	10090
33523018	1218	1224	Gly(2)	Chemical	MESH:D006033
33523018	1225	1230	GLP-2	Gene	93896
33523018	1290	1310	tyrosine hydroxylase	Gene	21823
33523018	1354	1360	Gly(2)	Chemical	MESH:D006033
33523018	1361	1366	GLP-2	Gene	93896
33523018	1391	1403	inflammation	Disease	MESH:D007249
33523018	1466	1471	NLRP3	Gene	216799
33523018	1476	1493	interleukin-1beta	Gene	16176
33523018	1498	1510	inflammatory	Disease	MESH:D007249
33523018	1580	1584	MPTP	Chemical	MESH:D015632
33523018	1593	1618	mitochondrial dysfunction	Disease	MESH:D028361
33523018	1712	1718	DA5-CH	Chemical	-
33523018	1769	1775	Gly(2)	Chemical	MESH:D006033
33523018	1776	1781	GLP-2	Gene	93896
33523018	1796	1801	NLRP3	Gene	216799
33523018	1824	1836	inflammation	Disease	MESH:D007249
33523018	1841	1861	mitochondrial damage	Disease	MESH:D028361
33523018	1897	1901	MPTP	Chemical	MESH:D015632
33523018	1907	1913	Gly(2)	Chemical	MESH:D006033
33523018	1914	1919	GLP-2	Gene	93896
33523018	1958	1960	PD	Disease	MESH:D010300
33523018	Negative_Correlation	MESH:D006033	MESH:D007249
33523018	Negative_Correlation	MESH:D006033	MESH:D028361
33523018	Positive_Correlation	MESH:D008569	93896
33523018	Negative_Correlation	MESH:D000544	93896
33523018	Association	MESH:D007249	216799
33523018	Positive_Correlation	MESH:D015632	MESH:D007249
33523018	Association	MESH:D028361	93896
33523018	Association	MESH:D006033	MESH:D015632
33523018	Positive_Correlation	21823	93896
33523018	Negative_Correlation	MESH:D007249	93896
33523018	Negative_Correlation	216799	93896
33523018	Negative_Correlation	16176	93896
33523018	Positive_Correlation	MESH:D015632	MESH:D010300
33523018	Negative_Correlation	MESH:D006033	216799
33523018	Positive_Correlation	MESH:D015632	MESH:D028361
33523018	Negative_Correlation	MESH:D006033	16176
33523018	Positive_Correlation	MESH:D006033	21823

